Home/Filings/4/0001104659-25-073786
4//SEC Filing

Richardson Peter C 4

Accession 0001104659-25-073786

CIK 0001567892other

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 8:48 PM ET

Size

6.3 KB

Accession

0001104659-25-073786

Insider Transaction Report

Form 4
Period: 2025-07-31
Richardson Peter C
EVP & Chief Scientific Officer
Transactions
  • Award

    Restricted Stock Units

    2025-07-31+20,51827,357 total
    Ordinary Shares (20,518 underlying)
Footnotes (2)
  • [F1]On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the "Transaction Agreement"), by and among Mallinckrodt plc (the "Issuer"), Endo, Inc. ("Endo") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary ("Merger Sub"), the Merger Sub merged with and into Endo (the "Business Combination"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer.
  • [F2]Upon consummation of the Business Combination, each performance unit ("PSU") held by the reporting person automatically converted into a restricted unit ("RSU"). Each RSU will fully vest on December 25, 2026.

Issuer

Mallinckrodt plc

CIK 0001567892

Entity typeother

Related Parties

1
  • filerCIK 0001343502

Filing Metadata

Form type
4
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 8:48 PM ET
Size
6.3 KB